权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Effect of randomized cocoa supplementation on inflammaging and epigenetic aging

随机补充可可对炎症和表观遗传衰老的影响

基本信息

批准号：
10451613
负责人：
Yanbin Dong
金额：
$ 72.09万
依托单位：
AUGUSTA UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-07-15 至 2025-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10451613
关键词：
Acceleration Adult Aging Ancillary Study Animal Model Anti-Inflammatory Agents Biological Aging Biology of Aging Blood C-reactive protein Cardiovascular Diseases Chocolate Chronic Cocoa Powder Collection Consumption DNA Methylation Dietary Intervention Disease Disease Outcome Disease susceptibility Double-Blind Method Effectiveness Elderly Epigenetic Process Flavanol Food Gene Expression Health Health Benefit Human In Vitro Inflammaging Inflammation Inflammatory Interleukin-1 beta Interleukin-4 Interleukin-6 Intervention Longevity Malignant Neoplasms Measures Mediating Molecular Morbidity - disease rate Multivitamin Observational Study Outcome Outcome Study Parents Participant Pathogenesis Personal Satisfaction Placebo Control Placebos Property Public Health Randomized Randomized Clinical Trials Randomized Controlled Trials Research Resources Risk Factors Role Sampling Serum Severities Supplementation TNF gene Testing Time Woman age related aged anti aging base cardiovascular disorder risk cohort cost cost effective cytokine dietary supplements epicatechin follow-up food consumption functional decline healthspan healthy aging human old age (65+)indexing insight interest lifestyle intervention men mortality mortality risk novel public health relevance recruit

项目摘要

PROJECT SUMMARY/ABSTRACT Cocoa products have become a widely consumed food, with growing demand across the world and steadily increasing interest in its potential health benefits and anti-aging biology. However, the role of cocoa consumption on epigenetic aging remains essentially unexplored. There has been compelling evidence for the anti- inflammatory role of cocoa and cocoa-derived flavanols based upon in vitro and animal models. However, a critical barrier of research progress remains the lack of definitive large-scale randomized controlled trials (RCTs). Accelerated epigenetic aging that comprises DNA methylation changes has recently emerged as a powerful, novel predictor for lifespan and health span, disease susceptibility, morbidity, and mortality risk. Further, inflammaging is a highly significant risk factor for both morbidity and mortality in the elderly, as many age-related diseases including cardiovascular disease (CVD) share an inflammatory pathogenesis. As such, interventions to slow or mitigate epigenetic aging and inflammaging are critical for promoting healthy aging. The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) is an ongoing randomized, double- blind, placebo-controlled, 2x2 factorial RCT of a high-quality cocoa extract supplement (containing 600 mg/d flavanols, including 80 mg epicatechins), and a multivitamin supplement to reduce the risk of CVD and cancer in women aged ≥65 years and men aged ≥60 years. COSMOS has randomized 21,444 participants into the trial, including 2,006 participants with bio-samples already collected at baseline, year 1 and year 2 follow-up. COSMOS is the only large RCT testing the effects of cocoa extract in women and men, and for multivitamins in women. Thus, this proposed ancillary study will build upon the parent COSMOS trial to examine the effects of randomized cocoa or multivitamin supplementation on anti-aging (epigenetic aging and inflammaging) in 600 representative subjects with three bio-sample collections at baseline, year 1, and year 2, as well as measured CVD risk factors, and examining these findings in the context of CVD outcomes. We will test our central hypotheses that cocoa supplementation reduces epigenetic aging indices (e.g., AgeAccelHorvath, AgeAccelHannum, AgeAccelGrim, AgeAccelPheno, and DNAmTLadjAge) and inflammaging (serum hsCRP, IL- 1β, IL-4, IL-6, and TNF-α) over time. We will also determine to what extent the effects of cocoa supplementation on inflammaging and CVD risk factors are mediated by epigenetic aging. The purported anti-aging health benefits of cocoa-rich products such as dark chocolate have popularized and increased consumption of cocoa-rich products over the past decade. Moreover, multivitamins remain the most common dietary supplement taken by at least one-third of older US adults. It remains of critical public health importance to rigorously test the anti-aging properties of these two supplements via large RCTs for more definitive evidence of their potential efficacy, and to approve or refute their potential anti-aging benefits.

项目总结/文摘